Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant – EurekAlert (press release)
|
Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant
EurekAlert (press release) ATLANTA – Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after a transplant with donor stem cells. Preliminary results from the first clinical trial in these patients … |
